CN116350725A - Traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof - Google Patents
Traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof Download PDFInfo
- Publication number
- CN116350725A CN116350725A CN202310333557.6A CN202310333557A CN116350725A CN 116350725 A CN116350725 A CN 116350725A CN 202310333557 A CN202310333557 A CN 202310333557A CN 116350725 A CN116350725 A CN 116350725A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- rhizome
- heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 title claims abstract description 51
- 206010022437 insomnia Diseases 0.000 title claims abstract description 49
- 230000007812 deficiency Effects 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 210000002216 heart Anatomy 0.000 claims abstract description 52
- 210000000952 spleen Anatomy 0.000 claims abstract description 34
- 239000002994 raw material Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 23
- 241000489492 Arisaema Species 0.000 claims description 18
- 241000132012 Atractylodes Species 0.000 claims description 18
- 210000000941 bile Anatomy 0.000 claims description 18
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 17
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 17
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 17
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 17
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 17
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 17
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 17
- 240000000171 Crataegus monogyna Species 0.000 claims description 17
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 17
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 17
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 17
- 244000150195 Cyperus longus Species 0.000 claims description 17
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 17
- 244000197580 Poria cocos Species 0.000 claims description 17
- 235000008599 Poria cocos Nutrition 0.000 claims description 17
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 17
- 240000001341 Reynoutria japonica Species 0.000 claims description 17
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 16
- 240000008866 Ziziphus nummularia Species 0.000 claims description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 230000004622 sleep time Effects 0.000 claims description 11
- 241000382455 Angelica sinensis Species 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 241001547127 Fritillaria cirrhosa Species 0.000 claims description 9
- 241000935235 Fritillaria meleagris Species 0.000 claims description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 9
- 241000112528 Ligusticum striatum Species 0.000 claims description 9
- 241001080798 Polygala tenuifolia Species 0.000 claims description 9
- 241000405911 Rehmannia glutinosa Species 0.000 claims description 9
- 235000006533 astragalus Nutrition 0.000 claims description 9
- 229940107666 astragalus root Drugs 0.000 claims description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 9
- 235000011477 liquorice Nutrition 0.000 claims description 9
- 241000605445 Anemarrhena asphodeloides Species 0.000 claims description 8
- 244000061520 Angelica archangelica Species 0.000 claims description 8
- 244000236521 Bupleurum rotundifolium Species 0.000 claims description 8
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 claims description 8
- 241000146384 Glaux Species 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- 241000212322 Levisticum officinale Species 0.000 claims description 8
- 241000405414 Rehmannia Species 0.000 claims description 8
- 239000001645 levisticum officinale Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 241000045403 Astragalus propinquus Species 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 244000088415 Raphanus sativus Species 0.000 claims 4
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 210000004185 liver Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 17
- 210000002784 stomach Anatomy 0.000 abstract description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 12
- 206010038743 Restlessness Diseases 0.000 abstract description 12
- 208000026435 phlegm Diseases 0.000 abstract description 12
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 10
- 210000005036 nerve Anatomy 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 2
- 210000004556 brain Anatomy 0.000 description 16
- 241000220259 Raphanus Species 0.000 description 13
- 230000007958 sleep Effects 0.000 description 12
- 208000002720 Malnutrition Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 230000001071 malnutrition Effects 0.000 description 7
- 235000000824 malnutrition Nutrition 0.000 description 7
- 208000015380 nutritional deficiency disease Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241001061264 Astragalus Species 0.000 description 5
- 206010024642 Listless Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000017971 listlessness Diseases 0.000 description 5
- 210000004233 talus Anatomy 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 4
- 230000008451 emotion Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 206010010305 Confusional state Diseases 0.000 description 3
- 208000006083 Hypokinesia Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000036578 sleeping time Effects 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000002618 waking effect Effects 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000032140 Sleepiness Diseases 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 230000004620 sleep latency Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UHFFFAOYSA-N 2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol Chemical compound OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 description 1
- KWQANSZTMNRIHA-IBRINFIGSA-N 2-amino-n-[3-hydroxy-2-methyl-6-[[(1s,3s)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl]oxy]oxan-4-yl]acetamide Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)C1CC(NC(=O)CN)C(O)C(C)O1 KWQANSZTMNRIHA-IBRINFIGSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 206010062350 Spleen malformation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 208000023505 abnormal feces Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229960004977 anhydrous lactose Drugs 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960000796 barbital sodium Drugs 0.000 description 1
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001531 copovidone Polymers 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000004617 sleep duration Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940045902 sodium stearyl fumarate Drugs 0.000 description 1
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia, which comprises the following raw materials in parts by weight: the invention has good effects of tonifying heart and spleen, harmonizing stomach and resolving stagnation, calming heart and soothing nerves, nourishing blood and soothing nerves, reducing phlegm and relieving turbid urine, soothing liver and relieving restlessness, and treating insomnia caused by heart and spleen deficiency.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof.
Background
Insomnia is called insomnia, its core disease is in the heart and brain, and the basic pathogenesis is that the heart and mind are restless due to malnutrition or disturbance of the spirit hidden in the heart and brain. Insomnia refers to viscera including heart, spleen, liver, kidney, gallbladder, stomach and brain, and its pathogenesis is divided into deficiency and excess. Deficiency syndrome is mainly caused by deficiency of yin and blood, malnutrition of heart and brain, and is characterized by weak constitution, lusterless complexion, listlessness, palpitation, amnesia, and tinnitus due to spleen malformation, liver malnutrition, kidney malnutrition, heart-mind malnutrition, and deficiency of brain and sea; the excessive syndrome is marked by excessive fire disturbing the mind or stagnant blood, and is characterized clinically by restlessness, irritability, bitter taste in the mouth, dry throat, constipation, dark urine, chest distress and pain, which are caused by excessive heart fire, liver depression transforming into fire, phlegm fire disturbing the heart and stagnant blood obstructing the collaterals.
The main disease location of insomnia is in the heart and brain. Insomnia due to malnutrition of heart-mind or disturbance of heart-mind, mental confusion; also, insomnia is caused by kidney essence deficiency and brain loss. Other viscera, such as liver, spleen, kidney, gallbladder, stomach, and other qi and blood imbalance of yin and yang, can disturb the mind of heart and brain to cause insomnia. At this time, it should be distinguished from the combination: for example, the patients with irritability and insomnia are mostly the internal disturbance of liver fire; pale complexion, tiredness and listlessness, while insomnia are mostly caused by spleen deficiency and loss of transportation; the complexion is pale, the mood is vexation, thinking is not absolute, the sleeping is not easy, the sleeping is easy to wake, and the sleeping is not easy to fall back after waking, so that the people mostly have deficiency of heart and spleen; restlessness, palpitation, dizziness, amnesia, waist-purgation, insomnia, excessive fire due to yin deficiency, and incoordination between heart and kidney; the night mare is linked with the sleep, and the heart and gallbladder deficiency is usually treated; gastric distress and greasy coating, while insomnia is usually caused by food retention and stagnation, and stomach qi disharmony.
Chinese invention patent: CN202011242587 discloses a Chinese medicinal preparation for treating insomnia due to internal disturbance of phlegm-heat and a preparation method thereof, which comprises three medicaments of rhizoma pinellinae praeparata, coptis chinensis and rhizoma corydalis which together form monarch medicaments for clearing heat and resolving phlegm, harmonizing stomach and lowering adverse qi and regulating spleen and stomach functions so as to achieve the aim of treating insomnia; chinese invention patent: CN201910327551 discloses a compound traditional Chinese medicine essential oil for treating insomnia, which takes lavender as a monarch, and has the effects of tranquilizing and allaying excitement, promoting qi circulation and dredging collaterals; takes cedarwood and benzoin as ministerial drugs to clear heart and induce resuscitation; the sandalwood, the dried orange peel and the clove are used for regulating qi and warming yang; cinnamon is used as a guide, and fire is led back to the element. The formula is matched and supplemented without stagnation, so that the qi stagnation is relieved, the mind is relieved, and the effects of soothing the nerves, aiding sleep, regulating qi and resolving stagnation are jointly exerted. The traditional Chinese medicine composition for treating insomnia caused by deficiency of both heart and spleen and application thereof are not found in the treatment concept of yin-middle-yang and yang-middle-yin in traditional Chinese medicine.
Disclosure of Invention
Aiming at the problems existing in the prior art, the invention provides a traditional Chinese medicine composition for treating insomnia caused by deficiency of heart and spleen, which comprises the following raw materials in parts by weight: 20-30 parts of astragalus membranaceus, 15-25 parts of bighead atractylodes rhizome, 20-30 parts of angelica sinensis, 15-25 parts of dried orange peel, 30-40 parts of hawthorn, 20-30 parts of malt, 15-25 parts of radish seed, 10-20 parts of nutgrass galingale rhizome, 20-30 parts of tuber fleeceflower stem, 10-20 parts of wild jujube seed, 20-30 parts of poria cocos, 10-20 parts of liquorice, 10-20 parts of poria with hostwood, 15-25 parts of rehmannia glutinosa, 10-20 parts of ligusticum wallichii, 15-25 parts of polygala tenuifolia, 8-12 parts of fritillaria cirrhosa, 15-20 parts of arisaema cum bile, 10-20 parts of radix bupleuri and 10-20 parts of rhizoma anemarrhenae.
Preferably, the traditional Chinese medicine composition comprises the following raw materials in parts by weight: 25 parts of astragalus membranaceus, 20 parts of bighead atractylodes rhizome, 25 parts of Chinese angelica, 20 parts of dried orange peel, 35 parts of hawthorn, 25 parts of malt, 20 parts of radish seed, 15 parts of nutgrass galingale rhizome, 25 parts of tuber fleeceflower stem, 15 parts of spina date seed, 25 parts of poria cocos, 15 parts of liquorice, 15 parts of poria with hostwood, 20 parts of rehmannia glutinosa, 15 parts of ligusticum wallichii, 20 parts of polygala tenuifolia, 10 parts of fritillaria cirrhosa, 18 parts of arisaema cum bile, 15 parts of radix bupleuri and 15 parts of rhizoma anemarrhenae.
Still further, the traditional Chinese medicine composition is prepared into clinically acceptable pharmaceutical preparations according to a traditional Chinese medicine conventional preparation method.
The traditional Chinese medicine composition is prepared into decoction, granules, powder, capsules, tablets, mixture or oral liquid.
The application of the traditional Chinese medicine composition in preparing a medicine for treating heart-spleen deficiency type insomnia.
The application of the traditional Chinese medicine composition in preparing the medicine for improving the sleep time of the heart-spleen deficiency type insomnia patient.
A medicine for treating insomnia caused by deficiency of heart and spleen is prepared from the traditional Chinese medicine composition and pharmaceutically acceptable auxiliary materials.
The preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) Taking the following raw materials according to the proportion of the traditional Chinese medicine composition: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour;
(2) Adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the liquid medicine after the decoction is finished;
(3) Adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out the medicinal liquid after the decoction is finished;
(4) Mixing the two medicinal liquids, bagging, and packaging to obtain one of decoction, mixture and oral liquid.
The preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) Taking the following raw materials according to the proportion of the traditional Chinese medicine composition: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour;
(2) Adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the liquid medicine after the decoction is finished;
(3) Adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out the medicinal liquid after the decoction is finished;
(4) Mixing the two medicinal liquids, concentrating, spray drying, adding adjuvants, and making into granule, powder, capsule, or tablet.
The auxiliary materials may include, for example, excipients, binders, disintegrants, lubricants, etc.
Excipients include starch, lactose, anhydrous lactose, microcrystalline cellulose, silicified microcrystalline cellulose, hypromellose, silicic anhydride, calcium phosphate, anhydrous calcium phosphate, dibasic calcium phosphate, anhydrous dibasic calcium phosphate, calcium silicate, dextrin, dextrose, dextran salt, mannitol, maltose, sorbitol, sucrose, polyethylene glycol, sodium chloride, and the like, and these may be used alone or in combination of two or more.
Disintegrants include crospovidone, croscarmellose sodium, sodium starch glycolate, pregelatinized starch, low-substituted hydroxypropylcellulose, cereal starch, etc., and these may be used alone or in combination of two or more.
Lubricants include magnesium stearate, stearic acid, talc, silica, colloidal silica, sodium stearyl fumarate, sodium lauryl sulfate, poloxamer and the like, and these may be used alone or in combination of two or more.
The binder includes povidone, copovidone, methylcellulose, hydroxymethyl cellulose, hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, gelatin, guar gum, xanthan gum, etc.
And (3) square solution:
insomnia syndrome, deficiency and excess are combined, and deficiency is more. For the deficiency, common pathogenesis is: 1. the seven emotions are extremely excessive, so that the five zang organs and the brain spirit can be influenced, and insomnia, especially overhappy, overanger, overstep and overstep are more common, because the change of the emotional stress often consumes the essence of the five zang organs, and the essence deficiency and the brain orifices lose nourishment, the brain spirit is not calm, and the insomnia is generated. The relationship among the heart, spleen and liver is the most closely. The heart stores spirit, overstrain heart, consume heart blood, and the heart fire is reddish with one's head, disturbing the mind; or the player is playing inordinately, the mind is excited, the mind is restless, and the player is easy to insomnia. Spleen stores, excessive thinking would damage spleen qi, cause biochemical fatigue, deficiency of qi and blood, and mental confusion. Liver stores blood, blood takes over spirit, anger hurts liver, qi stagnation turns into fire, spirit can not store, and insomnia is also caused. 2. Excessive labor, consumption of yin blood, or prolonged metrorrhagia, puerperal blood loss; the deficiency of qi and blood can be caused by the failure of the body after illness or major surgery or by the failure of the old to consume qi and blood, and insomnia can be caused by the lack of the nourishment of the heart spirit and the brain. There are also diseases such as vomiting, diarrhea, diet, fatigue, etc. which cause restlessness and insomnia due to spleen and stomach injury, spleen and stomach disharmony, anorexia, deficiency of qi and blood, and no nourishment of heart and brain. 3. If the essence is weak or the kidney yin of a patient suffering from a long-term illness is damaged, the heart cannot be acted on, and the water does not help with fire, the heart yang is solely excessive; or excessive five emotions, excessive heart fire, failure to descend to the kidneys, heart-kidney disharmony, excessive heart fire, disturbance of heat, mental confusion, restlessness and insomnia. "Jingyue holly............ Miscellaneous pattern, insomnia" says: the deficiency of true yin and essence and blood, disharmony between yin and yang, and uneasiness in the ear. The "ventricle" refers to the ventricle, and the true yin is not filled in the ventricle, so that the mind cannot be sustained, and insomnia occurs. 4. Impairment of the emotion, liver failure, depression of qi, fire transformation, and flaming up; or liver yin deficiency, liver yang hyperactivity disturbing brain spirit, unsteadiness of mind, and insomnia. 5. Heart deficiency timidity, no authority in resolution, easy convulsion, restlessness, insomnia. Insomnia is caused by frightening and hacking, emotional tension, and the vigilance of the whole day, gradually reaching the timidity of heart deficiency. Either due to deficiency or convulsion, they are often caused by each other, ultimately affecting brain orifices and failing to sleep. 6. The patients who feel too much, the liver qi is depressed, the spleen is not healthy and moves, and dampness is accumulated to generate phlegm; or, the long-term fei-gan-more-damp herbs can not transform into phlegm. If phlegm-fire is mixed and steamed, it will gather brain orifices and disturb the mind, and the mind is not in good care, resulting in insomnia and dreaminess. There are also those with excessive liver-gallbladder-stomach fire, which can activate phlegm-fire, which can disturb the clear orifices, restlessness, irritability, insomnia. The invention treats the heart and spleen deficiency, wherein the heart and spleen deficiency is the most common, and the heart and spleen is required to be tonified because the thought is too excessive and the liver qi is depressed and the spleen is not healthy, so that the heart and spleen deficiency is caused; secondly, due to the deficiency of both the heart and spleen, the spleen and stomach often have impaired transportation and transformation functions, abnormal spleen and stomach qi, abnormal stomach qi and yang floating outside, so that the patient is not safe to sleep, and clinically has the symptoms of abdominal distention, nausea, vomiting, eructation and acid regurgitation. Stomach harmonizing and stagnation resolving are needed; thirdly, due to deficiency of heart and spleen, heart deficiency and timidity are often accompanied, and the decision is not right, people are easy to fright and mind are not calm, so that insomnia is caused, and the heart is calm and tranquilized; the deficiency of both heart and spleen is often accompanied by chronic disease or metrorrhagia and metrostaxis of women, postpartum blood loss, deficiency of qi and blood, heart blood deficiency, heart failure, heart spirit malnutrition, blood nourishing and tranquillization; fifthly, phlegm-heat is often accompanied by deficiency of heart and spleen, and is obstructed to suppress upper disturbance of middle energizer, so that phlegm-heat is required to be resolved and turbid urine is required to be discharged; and six, because of heart-spleen deficiency, the emotion is often accompanied with the symptoms of depression, anger hurting the liver, liver qi stagnation, liver depression transforming into fire, the soul can not be stored, and liver soothing and restlessness relieving are needed. The whole formula is prepared from astragalus root, white atractylodes rhizome, chinese angelica, dried orange peel and tonifying heart and spleen; fructus crataegi, fructus Hordei Germinatus, raphani semen, rhizoma Cyperi, and stomach regulating and stagnation resolving, which are principal drugs, caulis Polygoni Multiflori, semen Ziziphi Spinosae, poria, glycyrrhrizae radix, and Poria, radix rehmanniae Preparata, rhizoma Ligustici Chuanxiong, and cortex et radix Polygalae with effects of nourishing blood and tranquilizing mind; fritillary bulb and arisaema cum bile are used as auxiliary drugs for resolving phlegm, discharging turbidity, bupleurum, rhizoma anemarrhenae, soothing liver and relieving restlessness, and the whole formula has remarkable effect of treating insomnia caused by deficiency of both heart and spleen.
Detailed Description
The invention is further described below in conjunction with the detailed description. It is to be understood that these examples are illustrative of the present invention and are not intended to limit the scope of the present invention. Further, it is understood that various changes and modifications of the present invention may be made by those skilled in the art after reading the description of the present invention, and that such equivalents are intended to fall within the scope of the claims appended hereto.
Example 1: 20g of astragalus, 25g of bighead atractylodes rhizome, 20g of Chinese angelica, 25g of dried orange peel, 30g of hawthorn, 30g of malt, 15g of radish seed, 20g of nutgrass galingale rhizome, 20g of tuber fleeceflower stem, 20g of wild jujube seed, 20g of poria cocos, 20g of liquorice, 10g of poria with hostwood, 25g of rehmannia glutinosa, 10g of ligusticum wallichii, 25g of polygala tenuifolia, 8g of fritillaria cirrhosa, 20g of arisaema cum bile, 10g of radix bupleuri and 20g of rhizoma anemarrhenae.
Example 2: 30g of astragalus, 15g of bighead atractylodes rhizome, 30g of Chinese angelica, 15g of dried orange peel, 40g of hawthorn, 20g of malt, 25g of radish seed, 10g of nutgrass galingale rhizome, 30g of tuber fleeceflower stem, 10g of wild jujube seed, 30g of poria cocos, 10g of liquorice, 20g of poria with hostwood, 15g of rehmannia glutinosa, 20g of ligusticum wallichii, 15g of polygala tenuifolia, 12g of fritillaria cirrhosa, 15g of arisaema cum bile, 20g of radix bupleuri and 10g of rhizoma anemarrhenae.
Example 3: 20g of astragalus, 15g of bighead atractylodes rhizome, 20g of Chinese angelica, 15g of dried orange peel, 30g of hawthorn, 20g of malt, 15g of radish seed, 10g of nutgrass galingale rhizome, 20g of tuber fleeceflower stem, 10g of wild jujube seed, 20g of poria cocos, 10g of liquorice, 10g of poria with hostwood, 15g of rehmannia glutinosa, 10g of ligusticum wallichii, 15g of polygala tenuifolia, 8g of fritillaria cirrhosa, 15g of arisaema cum bile, 10g of radix bupleuri and 10g of rhizoma anemarrhenae.
Example 4: 30g of astragalus, 25g of bighead atractylodes rhizome, 30g of Chinese angelica, 25g of dried orange peel, 40g of hawthorn, 30g of malt, 25g of radish seed, 20g of nutgrass galingale rhizome, 30g of tuber fleeceflower stem, 20g of wild jujube seed, 30g of poria cocos, 20g of liquorice, 20g of poria with hostwood, 25g of rehmannia glutinosa, 20g of ligusticum wallichii, 25g of polygala tenuifolia, 12g of fritillaria cirrhosa, 20g of arisaema cum bile, 20g of radix bupleuri and 20g of rhizoma anemarrhenae.
Example 5: 25g of astragalus, 20g of bighead atractylodes rhizome, 25g of Chinese angelica, 20g of dried orange peel, 35g of hawthorn, 25g of malt, 20g of radish seed, 15g of nutgrass galingale rhizome, 25g of tuber fleeceflower stem, 15g of wild jujube seed, 25g of poria cocos, 15g of liquorice, 15g of poria with hostwood, 20g of rehmannia glutinosa, 15g of ligusticum wallichii, 20g of polygala tenuifolia, 10g of fritillaria cirrhosa, 18g of arisaema cum bile, 15g of radix bupleuri and 15g of rhizoma anemarrhenae.
Example 6: decoction
The preparation method comprises the following steps:
the raw material medicines are respectively taken according to the weight parts of the following examples 1-5: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour; adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the raw materials after the decoction is finished; adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out; combining the two medicinal liquids, and packaging in bags.
Example 7: granule preparation
The preparation method comprises the following steps:
the raw material medicines are respectively taken according to the weight parts of the following examples 1-5: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour; adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the raw materials after the raw materials are decocted; adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out; mixing the two medicinal liquids, concentrating, spray drying, adding starch, and making into granule.
Example 8: tablet formulation
The preparation method comprises the following steps:
the raw material medicines are respectively taken according to the weight parts of the following examples 1-5: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour; adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the raw materials after the raw materials are decocted; adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out; mixing the two medicinal liquids, concentrating the medicinal liquid, spray drying, pulverizing, granulating, and making into tablet.
Example 9: capsule preparation
The preparation method comprises the following steps:
the raw material medicines are respectively taken according to the weight parts of the following examples 1-5: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour; adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the raw materials after the raw materials are decocted; adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out; mixing the two medicinal liquids, concentrating the medicinal liquid, spray drying, pulverizing, granulating, and making into capsule.
Example 10: pharmacodynamic test
Effect detection on mouse barbital sodium sleep time: the mice were randomly divided into 5 groups, i.e., physiological saline control group, granule group prepared by the prescription of example 1-3, stable positive control group, 12 each.
Group of examples: the fine powder of the medicine is infused with the stomach at the dosage of 10.0g/kg, the dosage of 5ml/kg and the dosage volume of 0.2ml/10g, and the stomach is infused;
stable positive control group: 1mg/kg of diazepam is administered and the stomach is irrigated;
saline control group: the same volume of physiological saline is administered and the stomach is irrigated.
60 minutes after gastric lavage, each group of mice was given 40mg/kg of pentobarbital sodium, respectively, for intraperitoneal injection. The sleep time of the mice (the disappearance of the flip-flop is regarded as the fall-to-sleep time, and the disappearance of the flip-flop to the recovery time is regarded as the sleep duration) was recorded.
The results are shown in Table 1.
TABLE 1 influence of sodium pentobarbital on sleep time in mice
Dosage (g/kg) | Sleep time (minutes) | |
Physiological saline group | 10 | 52.7±3.7 |
Example 1 granule group | 10 | 87.9±4.8* |
Example 2 granule group | 10 | 90.2±5.1* |
Example 3 granule group | 10 | 85.3±6.1* |
Stabilizing set | 0.001 | 118.8±6.4** |
P <0.05, P <0.01 compared to normal saline group
The results in the table show: the medicine of the invention obviously prolongs the sleeping time of mice and has obvious difference compared with normal saline group.
Example 11: clinical trial
Criteria for selecting cases: the valve has the following characteristics: (1) sleep latency is prolonged: the sleeping time exceeds 30min; (2) sleep maintenance disorder: the number of times of awakening at night is more than or equal to 2 or early awakening in the early morning; (3) sleep quality is degraded: shallow sleep and dreaminess; (4) total sleep time; shortening: typically < 5h; (5) daytime residual effect: the morning feels dizziness, listlessness, somnolence, hypodynamia and the like; the sleep disorder is at least 3 times per week and maintained for more than 1 month. The ages are 15-60 years, and can be used as the standard (inclusion standard) for selecting cases, and the cases are all cases of the subsidiary hospitals of the medical college of the conchoidal space.
Diagnostic criteria: according to the Chinese mental disorder classification and diagnosis standard: has the following characteristics: (1) sleep latency is prolonged: the sleeping time exceeds 30min; (2) sleep maintenance disorder: the number of times of awakening at night is more than or equal to 2 or early awakening in the early morning; (3) sleep quality is degraded: shallow sleep and dreaminess; (4) total sleep time. Shortening: typically < 5h; (5) daytime residual effect: the morning feels dizziness, listlessness, somnolence, hypodynamia, etc. The sleep disorder is at least 3 times per week and maintained for more than 1 month. According to the traditional Chinese medicine medical industry standard of the people's republic of China, the diagnosis and treatment effect standard of traditional Chinese medicine symptoms: the traditional Chinese medicine has the symptoms of insomnia caused by deficiency of heart and spleen, patients are not easy to fall asleep, or dreaminess is easy to wake up during sleep, and then are difficult to fall asleep after waking up, or palpitation, listlessness, hypodynamia, oral weakness, or abdominal distension after eating, nausea, abdominal pain, abnormal stool, poor appetite, sallow complexion, pale tongue with thin white or yellow coating, slow and weak pulse, and the patients can be diagnosed with insomnia caused by deficiency of heart and spleen through detection, and the traditional Chinese medicine is used for treating.
Treatment protocol: the traditional Chinese medicine oral liquid of the embodiment 1 is used for treating the patient with the diagnosis, and is orally taken twice a day, once a day, 20-30ml each time, 14 days as a treatment course, and the curative effect is counted.
Efficacy assessment criteria: according to the clinical study guidelines of new traditional Chinese medicines, (1) recovery, namely disappearance of clinical symptoms, recovery of sleep time to be normal or more than 6 hours, deep sleep and full energy after waking; (2) has obvious effects that clinical symptoms basically disappear, sleep is obviously improved, sleep time is increased by more than 3 h, and sleep depth is increased; (3) effective in alleviating symptoms and increasing sleep time by less than 3 h; (4) the insomnia is not obviously improved or aggravated after treatment.
And (3) statistical treatment: 100 patients with definite diagnosis are treated for 14 days, 62 patients are cured by statistical treatment, and 62 percent of the patients account for the obvious effects: 26 persons account for 26%, 7 persons are effective (improved), 7% are effective (improved), 5 persons are ineffective, the total effective rate is 95%, and no toxic or side effect is found in the treatment period, so that the medicine has stable and reliable curative effect and safe administration.
Conclusion: the traditional Chinese medicine composition has the advantages of scientific and reasonable components, safe and effective dosage, has the effects of tonifying heart and spleen, harmonizing stomach, relieving stagnation, calming heart, tranquillizing, nourishing blood, tranquillizing, resolving phlegm, discharging turbidity, soothing liver and relieving restlessness, is effectively used for treating heart-spleen deficiency type insomnia, has good curative effect, safe administration, high curative effect and total effective rate of up to 95 percent, is a great innovation in medicaments for treating heart-spleen deficiency type insomnia, and has good economic and social benefits.
Although embodiments of the present invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made therein without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (8)
1. The traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia is characterized by being prepared by extracting the following raw materials in parts by weight: 20-30 parts of astragalus membranaceus, 15-25 parts of bighead atractylodes rhizome, 20-30 parts of angelica sinensis, 15-25 parts of dried orange peel, 30-40 parts of hawthorn, 20-30 parts of malt, 15-25 parts of radish seed, 10-20 parts of nutgrass galingale rhizome, 20-30 parts of tuber fleeceflower stem, 10-20 parts of wild jujube seed, 20-30 parts of poria cocos, 10-20 parts of liquorice, 10-20 parts of poria with hostwood, 15-25 parts of rehmannia glutinosa, 10-20 parts of ligusticum wallichii, 15-25 parts of polygala tenuifolia, 8-12 parts of fritillaria cirrhosa, 15-20 parts of arisaema cum bile, 10-20 parts of radix bupleuri and 10-20 parts of rhizoma anemarrhenae.
2. The traditional Chinese medicine composition according to claim 1, wherein the traditional Chinese medicine composition is prepared by extracting the following raw materials in parts by weight: 25 parts of astragalus membranaceus, 20 parts of bighead atractylodes rhizome, 25 parts of Chinese angelica, 20 parts of dried orange peel, 35 parts of hawthorn, 25 parts of malt, 20 parts of radish seed, 15 parts of nutgrass galingale rhizome, 25 parts of tuber fleeceflower stem, 15 parts of spina date seed, 25 parts of poria cocos, 15 parts of liquorice, 15 parts of poria with hostwood, 20 parts of rehmannia glutinosa, 15 parts of ligusticum wallichii, 20 parts of polygala tenuifolia, 10 parts of fritillaria cirrhosa, 18 parts of arisaema cum bile, 15 parts of radix bupleuri and 15 parts of rhizoma anemarrhenae.
3. The traditional Chinese medicine composition according to claim 1 or 2, wherein the traditional Chinese medicine composition is prepared into clinically acceptable pharmaceutical preparations according to a traditional Chinese medicine conventional preparation method.
4. The Chinese medicinal composition according to claim 3, wherein the pharmaceutical preparation is a decoction, a granule, a powder, a capsule, a tablet, a mixture or an oral liquid.
5. The use of a Chinese medicinal composition according to claim 1 or 2 in the preparation of a medicament for treating insomnia due to deficiency of both heart and spleen.
6. The use of a Chinese medicinal composition according to claims 1-2 for the preparation of a medicament for improving sleep time in patients with insomnia due to deficiency of both heart and spleen.
7. The traditional Chinese medicine composition according to claim 1, wherein the preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) Taking the following raw materials in proportion: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour;
(2) Adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the liquid medicine after the decoction is finished;
(3) Adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out the medicinal liquid after the decoction is finished;
(4) Mixing the two medicinal liquids, bagging, and packaging to obtain one of decoction, mixture and oral liquid.
8. The traditional Chinese medicine composition according to claim 1, wherein the preparation method of the traditional Chinese medicine composition comprises the following steps:
(1) The traditional Chinese medicine composition according to claim 1 is prepared from the following raw materials: astragalus root, white atractylodes rhizome, angelica, dried orange peel, hawthorn, malt, radish seed, nutgrass galingale rhizome, tuber fleeceflower stem, wild jujube seed, indian buead, liquoric root, indian bread with hostwood, prepared rhizome of rehmannia, szechuan lovage rhizome, thinleaf milkwort root-bark, fritillary bulb, arisaema cum bile, chinese thorowax root and common anemarrhena rhizome are soaked in water for 1 hour;
(2) Adding 10 times of water into the raw materials for the first time, decocting for 1.5 hours, and pouring out the liquid medicine after the decoction is finished;
(3) Adding 10 times of water into the medicinal materials for the second time, decocting for 1 hour, and pouring out the medicinal liquid after the decoction is finished;
(4) Mixing the two medicinal liquids, concentrating, spray drying, adding adjuvants, and making into granule, powder, capsule, or tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310333557.6A CN116350725B (en) | 2023-03-31 | 2023-03-31 | Traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310333557.6A CN116350725B (en) | 2023-03-31 | 2023-03-31 | Traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116350725A true CN116350725A (en) | 2023-06-30 |
CN116350725B CN116350725B (en) | 2024-02-09 |
Family
ID=86941513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310333557.6A Active CN116350725B (en) | 2023-03-31 | 2023-03-31 | Traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116350725B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048982A (en) * | 2009-11-09 | 2011-05-11 | 孙胜波 | TCM for treating insomnia |
CN102100882A (en) * | 2009-12-17 | 2011-06-22 | 天津市中宝制药有限公司 | Chinese medicinal composition for treating insomnia |
-
2023
- 2023-03-31 CN CN202310333557.6A patent/CN116350725B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102048982A (en) * | 2009-11-09 | 2011-05-11 | 孙胜波 | TCM for treating insomnia |
CN102100882A (en) * | 2009-12-17 | 2011-06-22 | 天津市中宝制药有限公司 | Chinese medicinal composition for treating insomnia |
Non-Patent Citations (1)
Title |
---|
韩小磊等: "何华教授治疗不寐的经验点滴", 《中国中医药现代远程教育》, vol. 12, no. 9, pages 30 * |
Also Published As
Publication number | Publication date |
---|---|
CN116350725B (en) | 2024-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112057542B (en) | A Chinese medicinal composition for treating insomnia, anxiety, depression and climacteric syndrome, and its preparation method | |
CN115501304B (en) | Traditional Chinese medicine compound composition for treating heart-liver fire hyperactivity type insomnia and preparation method and application thereof | |
CN103405716A (en) | Herbal decoction for treating insomnia | |
CN103127472B (en) | Traditional Chinese medicine compound for refractory insomnia | |
CN115252753B (en) | Traditional Chinese medicine composition for treating insomnia and application thereof | |
CN104352793A (en) | Traditional Chinese medicine preparation for treating gastrointestinal bleeding and preparation method thereof | |
CN115350256B (en) | Traditional Chinese medicine composition for treating insomnia and preparation method thereof | |
CN116350725B (en) | Traditional Chinese medicine composition for treating heart-spleen deficiency type insomnia and application thereof | |
CN105456818A (en) | Traditional Chinese medicine composition containing folium artemisiae argyi and being capable of treating insomnia and preparation method of traditional Chinese medicine composition | |
CN115487239A (en) | Pharmaceutical composition for treating insomnia with anxiety and depression and preparation method thereof | |
CN113018338B (en) | Traditional Chinese medicine composition for treating diarrhea-predominant irritable bowel syndrome with anxiety and depression states and application thereof | |
CN100360152C (en) | Medicinal composition for treating insomnia and its preparing process | |
US20030143289A1 (en) | Herbal composition PHY828 and its use | |
CN105168541B (en) | A kind of Chinese medicine composition and the preparation method and application thereof with improvement sleep effect | |
CN105831751A (en) | Health-care traditional Chinese medicine composition with effects of tonifying qi and strengthening brain and preparation method and using method thereof | |
CN104998087A (en) | Traditional Chinese medicine composition for treating primary hypertension and preparing method of traditional Chinese medicine composition | |
CN104984097A (en) | Chinese herba preparation for treating primary hypertension and application thereof | |
CN110859949A (en) | Traditional Chinese medicine composition for treating infantile transient tic disorder and preparation method and application thereof | |
CN104689151A (en) | Traditional Chinese medicine composition for treating diabetes and use of composition | |
CN117159658B (en) | A Chinese medicinal composition for preventing, relieving or treating intractable insomnia, and its preparation method | |
CN110151877B (en) | Traditional Chinese medicine granule for treating tumor-related insomnia | |
CN107865953B (en) | Traditional Chinese medicine compound preparation for treating salivation and nocturia increase as well as preparation method and application thereof | |
CN105381341A (en) | Pharmaceutical composition for treating insomnia and preparation method thereof | |
CN114767790A (en) | Traditional Chinese medicine composition for treating hypertension and traditional Chinese medicine preparation and application thereof | |
CN106511881B (en) | A Chinese medicinal composition for invigorating kidney and preventing miscarriage, and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |